Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001019056-25-000253
Filing Date
2025-11-17
Accepted
2025-11-17 16:06:35
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10370
2 JOINT FILING AGREEMENT ex_1.htm EX-1 8495
  Complete submission text file 0001019056-25-000253.txt   20571
Mailing Address 220 E FIRST ST BETHLEHEM PA 18015
Business Address 220 E FIRST ST BETHLEHEM PA 18015 5036416115
ORASURE TECHNOLOGIES INC (Subject) CIK: 0001116463 (see all company filings)

EIN.: 364370966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-59673 | Film No.: 251491126
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1370 AVENUE OF THE AMERICAS 26TH FLOOR NEW YORK NY 10019
Business Address 1370 AVENUE OF THE AMERICAS 26TH FLOOR NEW YORK NY 10019 212-554-5000
GAGNON SECURITIES LLC (Filed by) CIK: 0001125725 (see all company filings)

EIN.: 134087058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G